Latest news with #HongKongSAR
Malay Mail
a day ago
- Business
- Malay Mail
Hong Kong rises to World's No.3 most competitive economy
Hong Kong rises to World's No.3 most competitive economy Hong Kong is one of the world's top three ranked global financial centres HONG KONG SAR - Media OutReach Newswire - 19 June 2025 - Hong Kong has moved up two places to rank as the world's third most competitive economy, marking the second successive year that the city has jumped two places in the global rankings to reach its highest position since World Competitiveness Yearbook 2025 (WCY 2025), published (June 17) by the Swiss-based International Institute for Management Development (IMD), assessed 69 economies around the world. Hong Kong made gains in all the factors of competitiveness: "Government efficiency" (second), "Business efficiency" (second) "Economic performance" (sixth), and "Infrastructure" (seventh). The IMD remarked that the gains across all four factors of competitiveness reflect a broad-based approach of Hong Kong to attracting private sector investment."The World Competitiveness Yearbook shows that Hong Kong's scores in overall terms and in many areas have improved, indicating that the Hong Kong Special Administrative Region (HKSAR) Government's policy directions are on the right course and that various policies have yielded results," said the HKSAR's Chief Executive John Kong has ranked among the top 10 in the world for over 20 consecutive years, since the WCY Lee said the ranking also "affirms Hong Kong's world-class business environment, reflecting business leaders' positive views on its competitiveness and strengths, including the rule of law, independent exercise of judicial power, a simple tax regime with low tax rates, an efficient and transparent market, a robust financial system, and a facilitating environment aligned with international best practices, as well as free flow of capital, information, goods and talent, which are affirmed by the business community."Despite the current uncertain global economic landscape and geopolitical turmoil, Hong Kong recorded solid year-on-year GDP growth of 3.1% in the first quarter of 2025, with full year GDP growth expected to be 2% to 3%.Totally, 145,053 local companies were newly registered under the Companies Ordinance last year, bringing the overall number of local companies registered to a record high of 1,460,494, at newly established non-Hong Kong companies were registered, bringing that overall total to an all-time high of 15,126."Under the unique advantages of 'one country, two systems', Hong Kong enjoys both the China advantage and the global advantage. We will continue to leverage Hong Kong's role as a 'super-connector' and 'super value-adder', strengthen international exchanges and co-operation, expand and deepen regional trade, explore new markets, with a view to building a vibrant economy, striving for development and improving people's livelihoods on all fronts," Mr Lee attract more non-Hong Kong incorporated companies to re-domicile to Hong Kong, the Government launched a new company re-domiciliation regime legislation last month, providing a simple and accessible mechanism for re-domiciliation to Hong two insurance companies, AXA Hong Kong and Macau (AXA China Region Insurance Company (Bermuda) Limited) and Manulife (International) Limited have announced plans to re-domicile to Hong Kong under the new regime, subject to regulatory Kong is actively driving reforms to strengthen and enhance its position as an international financial, trade, and shipping centre, trawling for businesses and talents. The Office for Attracting Strategic Enterprises has attracted over 80 strategic enterprises to establish offices in Hong Kong, bringing about HK$50 billion total investments in the years to come, and creating over 20,000 the sub-factors in the WCY 2025, Hong Kong came top for "Tax policy" and "Business legislation" and second for "Education", "International investment" and "Finance".Ranked as a top three global financial centre, Hong Kong's stock exchange is a key barometer of financial market performance. By May 30, 2025, stock market capitalisation had increased by 24% year-on-year to over US$5.2 the Hong Kong Stock Exchange has seen a surge in initial public offerings (IPOs), with total IPO funds raised reaching nearly HK$79 billion (US$10.12 billion) so far this year, making it the leader among major global #hongkong #brandhongkong #asiasworldcity #excellenthk #IMD #WorldCompetitiveness2025 The issuer is solely responsible for the content of this announcement.
Arabian Post
2 days ago
- Health
- Arabian Post
Hong Kong Baptist University and Elsevier Report Highlights Global Expansion of Chinese Medicine Research, Urges Standardised Frameworks for Broader Integration
HKBU and Elsevier launched a new report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine', highlighting the growing global impact of Chinese Medicine research in diversified healthcare solutions. ISTANBUL, TURKEY – Media OutReach Newswire – 18 June 2025 – The report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine' released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, 'Chinese Medicine research' encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field's rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine. Key findings from the report include: Rapid expansion : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. High scholarly impact : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. Interdisciplinary breadth : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. Global collaboration hubs : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. Emerging research foci : Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. : Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest. Bridging a global integration gap ADVERTISEMENT Chinese Medicine's mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact. ''Evolving Legacy' demonstrates how Chinese Medicine research has matured into a global, evidence-informed field,' said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine. 'We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.' 'This report offers unprecedented insights into Chinese Medicine's evolving scientific landscape,' added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. 'It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health.' The report was developed using Elsevier's bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on Hashtag: #HKBU The issuer is solely responsible for the content of this announcement.
Zawya
3 days ago
- Business
- Zawya
Henderson Land Sets Record for Central's Largest Single Office Lease
New Central Harbourfront Site 3 Project Leases Over 70% of Phase 1 Office Premises HONG KONG SAR - Media OutReach Newswire - 18 June 2025 - Henderson Land Development Company Limited ("Henderson Land" or "The Group") (Stock code 12) is delighted to announce that, through its subsidiary, it has entered into an Agreement for Lease with Jane Street, a quantitative trading firm and liquidity provider, as the first anchor tenant of the Group's latest New Central Harbourfront flagship development project. Jane Street will occupy over 223,000 square feet across six floors, leasing over 70% of the development's Phase 1 premium office and ancillary space. The signing of the lease is nearly two years ahead of the anticipated handover in early 2027. This lease marks the largest single office leasing transaction for Hong Kong's Central Business District in decades. Chairman of Henderson Land, Dr. Martin Lee Ka-shing, said: "We are proud to welcome Jane Street to our New Central Harbourfront flagship development project." He added, "Deeply rooted in Hong Kong, our Group is committed to advancing the city's core districts, and this anchor tenancy reinforces Hong Kong's unrivalled position as an international financial powerhouse. This development will reinvent Central by connecting the multi-worlds of retail, culture and commerce with nature and entertainment. Fuelled by the passion of our talented teams, we are confident that this global development will connect Hong Kong to the world stage, forging a bold new chapter for the city's future." The New Central Harbourfront project spans over 1.6 million square feet of gross floor area. This transformative project will not only redefine the city's iconic skyline, but also elevate Central as a cutting edge, vibrant global district. The 400 meter-long development includes 700,000 square feet of office and ancillary space that offers the largest premium Grade-A Office floor plates in Central, 900,000 square feet of retail space and the first Broadway-calibre theatre in Central. Inspired by a concept of "The Bridge", this people-centric development is a superconnector that seamlessly bridges Hong Kong and the world, enhances connectivity in Central and fosters integration with its surroundings – strengthening synergies between urban and nature, commerce and culture. The development provides an unprecedented 300,000 square feet of green and open spaces, including a rooftop garden for public enjoyment. It links Central district's vibrancy to the waterfront and the iconic Victoria Harbour, forming the new heart of Central. The site will unfold in two phases, with Phase 1 set for completion in the fourth quarter of 2026, and Phase 2 in 2032. Two years ahead of its first phase opening, the project has earned the highest standard industry certifications for its sustainability-focused architectural design, including awards and accreditations from LEED, BEAM Plus, WiredScore, Construction Industrial Council (CIC), Green Business Certification Inc., The Hong Kong Institute of Surveyors and Hong Kong Green Building Council. Hashtag: #HendersonLand The issuer is solely responsible for the content of this announcement. About Henderson Land Group Founded in 1976 and listed in Hong Kong since 1981, Henderson Land Development Company Limited (Stock code: 12) is a leading property group, focusing on Hong Kong and mainland China. Henderson Land is carrying on its legacy into the future, curating a property portfolio that grows from strength to strength and encompasses award-winning landmark projects such as the International Finance Centre complex and The Henderson. In addition to its core business in property development and property investment, the Group holds strategic investments in two listed subsidiaries (namely, Miramar Hotel and Investment Company Limited and Henderson Investment Limited) and three listed associates (namely, The Hong Kong and China Gas Company Limited (which in turn has equity stakes in a listed subsidiary, Towngas Smart Energy Company Limited), Hong Kong Ferry (Holdings) Company Limited and Sunlight Real Estate Investment Trust). Henderson Land is dedicated to the long-term commitment of sustainability and is a pioneer in green building and sustainable practices, which harness innovation and technology to create new, smarter living. The Group is also a strong advocate of social responsibility and invests in a broad range of community causes and initiatives. For more information, please visit About Jane Street Jane Street is a global quantitative trading firm and liquidity provider with expertise in a wide range of financial products, including ETFs, equities, futures, commodities, options, bonds, and currencies. Founded in 2000, Jane Street has offices in New York, London, Hong Kong, Amsterdam, and Singapore. Jane Street's global footprint allows it to make markets continually on more than 200 electronic exchanges and other trading venues in more than 45 countries around the world. Henderson Land Development Company Limited
Malay Mail
3 days ago
- Business
- Malay Mail
Henderson Land Sets Record for Central's Largest Single Office Lease
New Central Harbourfront Site 3 Project Leases Over 70% of Phase 1 Office Premises Aerial view of the project from Connaught Road to the harbourfront HONG KONG SAR - Media OutReach Newswire - 18 June 2025 - Henderson Land Development Company Limited ("Henderson Land" or "The Group") (Stock code 12) is delighted to announce that, through its subsidiary, it has entered into an Agreement for Lease with Jane Street, a quantitative trading firm and liquidity provider, as the first anchor tenant of the Group's latest New Central Harbourfront flagship development project. Jane Street will occupy over 223,000 square feet across six floors, leasing over 70% of the development's Phase 1 premium office and ancillary space. The signing of the lease is nearly two years ahead of the anticipated handover in early 2027. This lease marks the largest single office leasing transaction for Hong Kong's Central Business District in of Henderson Land, Dr. Martin Lee Ka-shing, said: "We are proud to welcome Jane Street to our New Central Harbourfront flagship development project." He added, "Deeply rooted in Hong Kong, our Group is committed to advancing the city's core districts, and this anchor tenancy reinforces Hong Kong's unrivalled position as an international financial powerhouse. This development will reinvent Central by connecting the multi-worlds of retail, culture and commerce with nature and entertainment. Fuelled by the passion of our talented teams, we are confident that this global development will connect Hong Kong to the world stage, forging a bold new chapter for the city's future."The New Central Harbourfront project spans over 1.6 million square feet of gross floor area. This transformative project will not only redefine the city's iconic skyline, but also elevate Central as a cutting edge, vibrant global 400 meter-long development includes 700,000 square feet of office and ancillary space that offers the largest premium Grade-A Office floor plates in Central, 900,000 square feet of retail space and the first Broadway-calibre theatre in by a concept of "The Bridge", this people-centric development is a superconnector that seamlessly bridges Hong Kong and the world, enhances connectivity in Central and fosters integration with its surroundings – strengthening synergies between urban and nature, commerce and culture. The development provides an unprecedented 300,000 square feet of green and open spaces, including a rooftop garden for public enjoyment. It links Central district's vibrancy to the waterfront and the iconic Victoria Harbour, forming the new heart of Central. The site will unfold in two phases, with Phase 1 set for completion in the fourth quarter of 2026, and Phase 2 in years ahead of its first phase opening, the project has earned the highest standard industry certifications for its sustainability-focused architectural design, including awards and accreditations from LEED, BEAM Plus, WiredScore, Construction Industrial Council (CIC), Green Business Certification Inc., The Hong Kong Institute of Surveyors and Hong Kong Green Building #HendersonLand The issuer is solely responsible for the content of this announcement. About Henderson Land Group Founded in 1976 and listed in Hong Kong since 1981, Henderson Land Development Company Limited (Stock code: 12) is a leading property group, focusing on Hong Kong and mainland China. Henderson Land is carrying on its legacy into the future, curating a property portfolio that grows from strength to strength and encompasses award-winning landmark projects such as the International Finance Centre complex and The Henderson. In addition to its core business in property development and property investment, the Group holds strategic investments in two listed subsidiaries (namely, Miramar Hotel and Investment Company Limited and Henderson Investment Limited) and three listed associates (namely, The Hong Kong and China Gas Company Limited (which in turn has equity stakes in a listed subsidiary, Towngas Smart Energy Company Limited), Hong Kong Ferry (Holdings) Company Limited and Sunlight Real Estate Investment Trust). Henderson Land is dedicated to the long-term commitment of sustainability and is a pioneer in green building and sustainable practices, which harness innovation and technology to create new, smarter living. The Group is also a strong advocate of social responsibility and invests in a broad range of community causes and initiatives. For more information, please visit About Jane Street Jane Street is a global quantitative trading firm and liquidity provider with expertise in a wide range of financial products, including ETFs, equities, futures, commodities, options, bonds, and currencies. Founded in 2000, Jane Street has offices in New York, London, Hong Kong, Amsterdam, and Singapore. Jane Street's global footprint allows it to make markets continually on more than 200 electronic exchanges and other trading venues in more than 45 countries around the world.
Arabian Post
3 days ago
- Health
- Arabian Post
Hong Kong Baptist University and Elsevier Report Charts Global Growth of Chinese Medicine Research, Calls for Standardised Frameworks for Broader Integration
HKBU and Elsevier launched a new report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine', highlighting the growing global impact of Chinese Medicine research in diversified healthcare solutions. ISTANBUL, TURKEY – Media OutReach Newswire – 17 June 2025 – The report 'Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine' released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, 'Chinese Medicine research' encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field's rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine. Key findings from the report include: Rapid expansion : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. High scholarly impact : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. Interdisciplinary breadth : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. Global collaboration hubs : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. Emerging research foci : Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. : Top-published trending topics include 'Herbaceous Agent | Chinese Medicine | Network Pharmacology' and COVID-19 applications, reflecting integration of omics, AI and systems methods. Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest. Bridging a global integration gap ADVERTISEMENT Chinese Medicine's mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact. ''Evolving Legacy' demonstrates how Chinese Medicine research has matured into a global, evidence-informed field,' said Professor Lyu Aiping, Vice-President (Research & Development), HKBU, and a leading expert in Chinese Medicine. 'We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.' 'This report offers unprecedented insights into Chinese Medicine's evolving scientific landscape,' added Basak Candemir, Business Development Director, Analytical and Data Services, Elsevier. 'It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health.' The report was developed using Elsevier's bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on Hashtag: #HKBU The issuer is solely responsible for the content of this announcement.
